The multifaceted roles of small extracellular vesicles in metabolic reprogramming in the tumor microenvironments

Zhixian Chen1, Judy Wai Ping Yam1, Xiaowen Mao2

  • 1Department of Pathology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.

Proteomics
|January 3, 2024
PubMed

Insights

Small extracellular vesicles (sEVs) are key players in tumor progression, mediating communication between cancer cells, macrophages, and fibroblasts. This review summarizes how sEVs alter metabolism in the tumor microenvironment and suggests therapeutic targets.

Area of Science:

  • Oncology
  • Cell Biology
  • Metabolic Research

Background:

  • The relationship between metabolism and tumor progression is complex and involves intricate regulatory networks within the tumor microenvironment.
  • Metabolic reprogramming is increasingly recognized for its multifaceted roles in cancer development and progression.
  • Intercellular communication is vital in shaping the tumor microenvironment, with small extracellular vesicles (sEVs) emerging as critical mediators.

Purpose of the Study:

  • To review and summarize the diverse functions of sEVs in modulating cellular metabolism within the tumor microenvironment.
  • To highlight the complex feedback loops established by sEVs derived from various cell types (tumor cells, TAMs, CAFs).
  • To identify potential therapeutic targets based on the mechanisms of sEV-mediated metabolic reprogramming.

Main Methods:

  • Comprehensive literature review of recent studies on sEVs and tumor metabolism.
  • Analysis of research focusing on sEVs derived from tumor cells, tumor-associated macrophages (TAMs), and cancer-associated fibroblasts (CAFs).
  • Synthesis of findings regarding the impact of sEVs on metabolic reprogramming in different cell types within the tumor microenvironment.

Main Results:

  • sEVs play a significant role in facilitating intercellular communication and regulating metabolic reprogramming in tumor microenvironments.
  • sEVs from tumor cells, TAMs, and CAFs engage in mutual interactions, creating complex feedback loops that influence tumor progression.
  • Specific mechanisms by which sEVs alter metabolism in various cell types have been identified across multiple studies.

Conclusions:

  • sEVs are crucial regulators of metabolic reprogramming within the tumor microenvironment, impacting cancer progression.
  • Understanding the intricate roles of sEVs in intercellular communication offers new avenues for therapeutic intervention.
  • Targeting sEV-mediated metabolic pathways presents a promising strategy for cancer treatment.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K